| 摘要 |
Disclosed is the use of an alpha-MSH analogue in the manufacture of a medicament for prophylactic or therapeutic treatment of photodermatoses that are caused, or exacerbated by, or that are induced, activated, provoked, evoked, or aggravated with UVR exposure in a subject.
|
